These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


323 related items for PubMed ID: 15737190

  • 21. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS, Palmer RA, Garibaldinos TT, Hawk JL.
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [Abstract] [Full Text] [Related]

  • 22. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
    Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei Q.
    J Natl Cancer Inst; 2005 Dec 21; 97(24):1822-31. PubMed ID: 16368944
    [Abstract] [Full Text] [Related]

  • 23. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS.
    Blood Cells; 1992 Dec 21; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [Abstract] [Full Text] [Related]

  • 24. The relationship between UV exposure and incidence of skin cancer.
    Moan J, Grigalavicius M, Baturaite Z, Dahlback A, Juzeniene A.
    Photodermatol Photoimmunol Photomed; 2015 Jan 21; 31(1):26-35. PubMed ID: 25213656
    [Abstract] [Full Text] [Related]

  • 25. Metal arc welding and the risk of skin cancer.
    Heltoft KN, Slagor RM, Agner T, Bonde JP.
    Int Arch Occup Environ Health; 2017 Nov 21; 90(8):873-881. PubMed ID: 28766013
    [Abstract] [Full Text] [Related]

  • 26. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients.
    Slaper H, Schothorst AA, van der Leun JC.
    Photodermatol; 1986 Oct 21; 3(5):271-83. PubMed ID: 3822871
    [Abstract] [Full Text] [Related]

  • 27. Carcinogenicity of combined ultraviolet B radiation and psoralen plus ultraviolet A irradiation treatment of mice.
    Granstein RD, Morison WL, Kripke ML.
    Photodermatol Photoimmunol Photomed; 1986 Oct 21; 9(5):198-202. PubMed ID: 1342188
    [Abstract] [Full Text] [Related]

  • 28. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis.
    Dawe RS, Cameron H, Yule S, Man I, Wainwright NJ, Ibbotson SH, Ferguson J.
    Br J Dermatol; 2003 Jun 21; 148(6):1194-204. PubMed ID: 12828749
    [Abstract] [Full Text] [Related]

  • 29. Association between dietary fat and skin cancer in an Australian population using case-control and cohort study designs.
    Granger RH, Blizzard L, Fryer JL, Dwyer T.
    BMC Cancer; 2006 May 30; 6():141. PubMed ID: 16734890
    [Abstract] [Full Text] [Related]

  • 30. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS, Nichols KT, Väkevä LH.
    N Engl J Med; 1997 Apr 10; 336(15):1041-5. PubMed ID: 9091799
    [Abstract] [Full Text] [Related]

  • 31. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
    Maiorino A, De Simone C, Perino F, Caldarola G, Peris K.
    J Dermatolog Treat; 2016 Oct 10; 27(5):443-7. PubMed ID: 26822468
    [Abstract] [Full Text] [Related]

  • 32. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study.
    El-Mofty M, El-Darouty M, Salonas M, Bosseila M, Sobeih S, Leheta T, Nada H, Tawdy A, Amin I, El-Enany G.
    Photodermatol Photoimmunol Photomed; 2005 Dec 10; 21(6):281-6. PubMed ID: 16313238
    [Abstract] [Full Text] [Related]

  • 33. Patterns of Ultraviolet Radiation Exposure and Skin Cancer Risk: the E3N-SunExp Study.
    Savoye I, Olsen CM, Whiteman DC, Bijon A, Wald L, Dartois L, Clavel-Chapelon F, Boutron-Ruault MC, Kvaskoff M.
    J Epidemiol; 2018 Jan 05; 28(1):27-33. PubMed ID: 29176271
    [Abstract] [Full Text] [Related]

  • 34. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks.
    Gasparro FP, Liao B, Foley PJ, Wang XM, McNiff JM.
    Environ Mol Mutagen; 1998 Jan 05; 31(2):105-12. PubMed ID: 9544188
    [Abstract] [Full Text] [Related]

  • 35. Ultraviolet radiation.
    Gallagher RP, Lee TK, Bajdik CD, Borugian M.
    Chronic Dis Can; 2010 Jan 05; 29 Suppl 1():51-68. PubMed ID: 21199599
    [Abstract] [Full Text] [Related]

  • 36. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer.
    Rigel DS.
    J Am Acad Dermatol; 2008 May 05; 58(5 Suppl 2):S129-32. PubMed ID: 18410798
    [Abstract] [Full Text] [Related]

  • 37. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.
    Leiter U, Garbe C.
    Adv Exp Med Biol; 2008 May 05; 624():89-103. PubMed ID: 18348450
    [Abstract] [Full Text] [Related]

  • 38. The epidemiology of UV induced skin cancer.
    Armstrong BK, Kricker A.
    J Photochem Photobiol B; 2001 Oct 05; 63(1-3):8-18. PubMed ID: 11684447
    [Abstract] [Full Text] [Related]

  • 39. Skin cancer incidence among atomic bomb survivors from 1958 to 1996.
    Sugiyama H, Misumi M, Kishikawa M, Iseki M, Yonehara S, Hayashi T, Soda M, Tokuoka S, Shimizu Y, Sakata R, Grant EJ, Kasagi F, Mabuchi K, Suyama A, Ozasa K.
    Radiat Res; 2014 May 05; 181(5):531-9. PubMed ID: 24754560
    [Abstract] [Full Text] [Related]

  • 40. [UV exposure, skin cancer and decrease in the ozone layer].
    Rauterberg A, Jung EG.
    Ther Umsch; 1993 Dec 05; 50(12):804-7. PubMed ID: 8171400
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.